1. The economic consequences of diabetes and cardiovascular disease in the United States

   • Miguel A. Ariza
   • Varsha G. Vimalananda
   • James L. Rosenzweig

   OriginalPaper 27 February 2010 Pages: 1 - 10

   

2. Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus

   • Neal B. Patel
   • Gary J. Balady

   OriginalPaper 12 March 2010 Pages: 11 - 20

   

3. Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitus

   • Hylton V. Joffe
   • Mary H. Parks
   • Robert Temple

   OriginalPaper 02 March 2010 Pages: 21 - 30

4. Diabetic cardiomyopathy, causes and effects

   • Sihem Boudina
   • Evan Dale Abel

   OriginalPaper 24 February 2010 Pages: 31 - 39

   

5. Management of dyslipidemia in people with type 2 diabetes mellitus

   • Fredrick L. Dunn

   OriginalPaper 10 March 2010 Pages: 41 - 51

6. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community

   • David S. Siscovick
   • Nona Sotoodehnia
   • Rozenn N. Lemaitre

   OriginalPaper 27 February 2010 Pages: 53 - 59

7. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications

   • Corey E. Tabit
   • William B. Chung
   • Joseph A. Vita

   OriginalPaper 26 February 2010 Pages: 61 - 74

   

8. Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting

   • Doron Aronson
   • Elazer R. Edelman

   OriginalPaper 11 March 2010 Pages: 75 - 86

   

9. Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting

   • Matteo Anselmino
   • Klas Malmberg
   • Lars Rydén

   OriginalPaper 06 March 2010 Pages: 87 - 94